Argus Cognitive, Inc.
United StatesFDA applicant, unverified FDA FEI 3036502204
- Devices
- 3
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Argus Cognitive, Inc. makes
Argus Cognitive, Inc. develops the ReVISION Software, a digital solution designed to enhance visual processing and assist individuals with visual impairments by providing real-time visual feedback and guidance.
The ReVISION Software is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Neurora Ref K260064
Regimes: 510(k) Registry: 510(k)ReVISION 2 Ref K251417
Regimes: 510(k) Registry: 510(k)Argus Cognitive ReVISION Software Ref K223322
Regimes: 510(k) Registry: 510(k)
Company details
- FDA FEI number
- 3036502204
- Address
- 35 S Main St, Hanover, NH, 03755
Frequently asked questions
How many devices does Argus Cognitive, Inc. have in the registry?
The registry currently lists 3 devices for Argus Cognitive, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Argus Cognitive, Inc.'s devices?
Among its 3 most recently registered devices, Argus Cognitive, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Argus Cognitive, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Argus Cognitive, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Argus Cognitive, Inc. in the registry?
The most recently registered devices listed for Argus Cognitive, Inc. include Neurora, ReVISION 2 and Argus Cognitive ReVISION Software.